Metabolon is happy to participate in the 6th Global NASH Congress held in London, United Kingdom. The congress brings together experts and leaders in the field of non-alcoholic steatohepatitis (NASH) research with a focus on understanding the disease’s mechanisms, developments in non-invasive diagnostic biomarkers and improvements to in vivo liver models.
Recent Comments